Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
254
datasets available to search
ShareScore release 0.9.0
Dataset results
254 results for “Subarachnoid hemorrhage”
Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH)
ClinicalTrials.gov study NCT04876638. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Trial
ClinicalTrials.gov study NCT02875262. IPD Sharing: YES. Countries: 1. Publications: 1.
Epigenome-wide DNA Methylation Profiling in Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurologic Deficit
ClinicalTrials.gov study NCT06881329. IPD Sharing: YES. Countries: 1. Publications: 1.
MicroRNA Diagnostics in Subarachnoid Hemorrhage
ClinicalTrials.gov study NCT01791257. IPD Sharing: Not stated. Countries: 1. Publications: 2.
3D Contrast Enhanced Acoustic Perfusion Imaging in Adult After Subarachnoid Hemorrhage
ClinicalTrials.gov study NCT06793839. IPD Sharing: NO. Countries: 1. Publications: 2.
Cerebrospinal Fluid Hemoglobin to Monitor for Aneurysmal Subarachnoid Hemorrhage Related Secondary Brain Injury
ClinicalTrials.gov study NCT04998370. IPD Sharing: UNDECIDED. Countries: 3. Publications: 1.
Superior Cervical Sympathetic Block Versus Stellate Ganglion Block in Post-traumatic Subarachnoid Hemorrhage
ClinicalTrials.gov study NCT06134583. IPD Sharing: NO. Countries: 0. Publications: 10.
Impact of Herniation on WFNS Grading in Spontaneous Subarachnoid Hemorrhage - a SWISS SOS Observational Trial
ClinicalTrials.gov study NCT02304328. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Extracorporeal Filtration of Subarachnoid Hemorrhage Via Spinal Catheter
ClinicalTrials.gov study NCT02872636. IPD Sharing: NO. Countries: 1. Publications: 1.
Acupuncture for Cerebral Vasospasm After Subarachnoid Hemorrhage
ClinicalTrials.gov study NCT02275949. IPD Sharing: NO. Countries: 1. Publications: 3.
Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)
ClinicalTrials.gov study NCT04148105. IPD Sharing: YES. Countries: 1. Publications: 15.
Osmotic Therapy for Patients With Severe Subarachnoid Hemorrhage
ClinicalTrials.gov study NCT05858060. IPD Sharing: Not stated. Countries: 1. Publications: 1.
IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage
ClinicalTrials.gov study NCT07054801. IPD Sharing: NO. Countries: 1. Publications: 0.
Data from: Clinical complications and outcomes of angiographically negative subarachnoid hemorrhage
Objective: To define the in-hospital course, complications, short- and long-term functional outcomes of patients with angiographically negative subarachnoid hemorrhage (anSAH), particularly those with aneurysmal-pattern anSAH (aanSAH). Methods: Retrospective cohort study of patients with aneurysmal subarachnoid hemorrhage (aSAH), aanSAH and perimesencephalic-pattern anSAH (panSAH) treated at a single tertiary referral center between January 2006 and April 2018. Ninety-nine patients with anSAH (33 aanSAH and 66 panSAH) and 464 patients with aSAH were included in this study. Outcomes included symptomatic hydrocephalus requiring CSF drainage, need for ventriculoperitoneal shunt (VPS), radiographic vasospasm, delayed cerebral ischemia (DCI), radiographic infarction, disability level within one year of ictus and at last clinical follow-up as defined by modified Rankin Scale (mRS). Results: Patients with aanSAH and panSAH had similar rates of DCI and radiologic infarction, and patients with aanSAH had significantly lower rates compared to aSAH (P≤0.018). Patients with aanSAH were more likely than those with panSAH to require temporary CSF diversion and VPS (P≤0.03), with similar rates to those seen in aSAH. Only one patient with anSAH died in the hospital. Compared to those with aSAH, patients with aanSAH were significantly less likely to have a poor functional outcome within one year of ictus (OR 0.26, 95% CI 0.090 – 0.75) and at last follow-up (HR 0.30, 95% CI 0.19 – 0.49, P=0.002). Conclusions: DCI is very uncommon in anSAH, but patients with aanSAH have a similar need for short- and long-term CSF diversion to patients with aSAH. Nevertheless, patients with aanSAH have significantly better short- and long-term outcomes.
Data from: Association between aspirin dose and subarachnoid hemorrhage from saccular aneurysms: a case-control study
Objective: We aimed to determine the association between ruptured saccular aneurysms and aspirin use/aspirin dose. Methods: 4,701 patients who were diagnosed at the Massachusetts General Hospital and Brigham and Women's Hospital between 1990 and 2016 with 6,411 unruptured and ruptured saccular intracranial aneurysms were evaluated. Univariable and multivariable logistic regression analyses were performed to determine the association between aSAH and aspirin use, including aspirin dose. Inverse probability weighting using propensity scores was used to adjust for potential differences in baseline characteristics between cases and controls. Additional analyses were performed to examine the association of aspirin use and re-rupture prior to treatment. Results: In multivariate analysis with propensity score weighting, aspirin use (OR 0.60, 95% CI 0.45-0.80) was significantly associated with decreased risk of ruptured intracranial aneurysms. There was a significant inverse dose-response relationship between aspirin dose and aneurysmal subarachnoid hemorrhage (OR 0.65, 95% CI 0.53-0.81). In contrast, there was a significant association between aspirin use and increased risk of re-rupture prior to treatment (OR 8.15, 95% CI 2.22-30.0). Conclusions: In this large case-control study, aspirin therapy at diagnosis was associated with a significantly decreased risk of subarachnoid hemorrhage, with an inverse dose-response relationship among aspirin users. However, once rupture has occurred, aspirin is associated with an increased risk of re-rupture prior to treatment.
Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)
ClinicalTrials.gov study NCT06559072. IPD Sharing: YES. Countries: 1. Publications: 0.
Trial of Long-term Therapeutic Hypothermia for Poor-grade Aneurysmal Subarachnoid Hemorrhage
ClinicalTrials.gov study NCT03442608. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage
ClinicalTrials.gov study NCT02176837. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study of Ketamine Sedation for Aneurysmal Subarachnoid Hemorrhage
ClinicalTrials.gov study NCT05032118. IPD Sharing: NO. Countries: 0. Publications: 8.
Prolonged Vasospasm in Subarachnoid Hemorrhage
ClinicalTrials.gov study NCT04193124. IPD Sharing: NO. Countries: 0. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.